Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Citalopram hydrobromide

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Citalopram Hbr Manufacturers in India Suppliers Citalopram Hbr Exporters Distributors Citalopram Hbr api active pharmaceuticals ingredients Citalopram Hbr manufacturers Side Effects bulk drugs raw material Citalopram Hbr companies Side Effects Importers Citalopram Hbr Citalopram Hbr Exporters Citalopram Hbr exporters FDA Citalopram Hbr DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Citalopram Hydrobromide manufacturing pharmaceutical drugs pharmaceutical intermediates Citalopram Hydrobromide pharmaceutical chemicals pharmaceutical raw materials Citalopram Hydrobromide active pharmaceutical ingredients Citalopram Hydrobromide committee active pharmaceutical ingredients manufacturer Citalopram Hydrobromide Active Pharmaceutical Ingredients manufacturer Citalopram Hydrobromide exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Citalopram Hbr, Citalopram Hbr manufacturer India, Citalopram Hbr product, Citalopram Hbr products, Api preparation, Certificate of Analysis API manufacturer product, Citalopram Hbr anti ulcer product, Certificate of Origin COA Citalopram Hbr COS Citalopram Hbr, pharmaceutical generic, pharmaceutical drug, medical, Citalopram Hbr pharma healthcare, pharma patents, contract MSDS manufacturing Trader Citalopram Hbr pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Citalopram Hbr expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Citalopram Hbr DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Citalopram Hbr ingredients, api, HIV Citalopram Hbr, tablets, capsules, syrup & protein Citalopram Hbr powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Citalopram Hbr gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Citalopram Hbr WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Citalopram hydrobromide



















 


 





 

 

HOME >> API >> API List1 >> Citalopram Hbr >> Interaction

 Citalopram hydrobromide CAS Registry Number 59729-32-7

INTERACTION
Citalopram hydrobromide CAS Number 59729-32-7

All SSRIs, including citalopram, should not be taken with any of the mono-amine oxidase (MAO) inhibitor-class of antidepressants,combinations may lead to confusion, high blood pressure, tremor, and hyperactivity. If treatment is to be changed from citalopram to an MAOI or vice-versa, there should be a 14 day period without either drug before the alternative drug is started. Tryptophan, a common dietary supplement, can cause headaches, nausea, sweating, and dizziness when taken with any SSRI.

Use of an SSRI with aspirin, nonsteroidal anti-inflammatory drugs or other drugs that affect bleeding may increase the likelihood of upper gastrointestinal bleeding.

Do not take citalopram together with a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate). You must wait at least 14 days after stopping an MAOI before you can take citalopram. After you stop taking this medication, you must wait at least 14 days before you start taking an MAOI.

You may have thoughts about suicide when you first start taking an antidepressant, especially if you are younger than 24 years old. Your doctor will need to check you at regular visits for at least the first 12 weeks of treatment with citalopram.

Call your doctor at once if you have any new or worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself. Some antidepressants may cause serious or life-threatening lung problems in newborn babies whose mothers take the medication during pregnancy. However, you may have a relapse of depression if you stop taking your antidepressant during pregnancy. If you are planning a pregnancy, or if you become pregnant while taking citalopram, do not stop taking the medication without first talking to your doctor.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION >>
PHARMALOGY
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Citalopram Hbr

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.